Search details
1.
Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19.
N Engl J Med
; 387(7): 599-610, 2022 08 18.
Article
in English
| MEDLINE | ID: mdl-36070710
2.
Favorable Antiviral Effect of Metformin on Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load in a Randomized, Placebo-Controlled Clinical Trial of Coronavirus Disease 2019.
Clin Infect Dis
; 2024 May 01.
Article
in English
| MEDLINE | ID: mdl-38690892
3.
Impact of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccination and Booster on Coronavirus Disease 2019 (COVID-19) Symptom Severity Over Time in the COVID-OUT Trial.
Clin Infect Dis
; 76(3): e1-e9, 2023 02 08.
Article
in English
| MEDLINE | ID: mdl-36124697
4.
Are fewer cases of diabetes mellitus diagnosed in the months after SARS-CoV-2 infection? A population-level view in the EHR-based RECOVER program.
J Clin Transl Sci
; 7(1): e90, 2023.
Article
in English
| MEDLINE | ID: mdl-37125061
5.
Strategies used for the COVID-OUT decentralized trial of outpatient treatment of SARS-CoV-2.
J Clin Transl Sci
; 7(1): e242, 2023.
Article
in English
| MEDLINE | ID: mdl-38033705
6.
Metformin reduces SARS-CoV-2 in a Phase 3 Randomized Placebo Controlled Clinical Trial.
medRxiv
; 2023 Jun 07.
Article
in English
| MEDLINE | ID: mdl-37333243
7.
Are fewer cases of diabetes mellitus diagnosed in the months after SARS-CoV-2 infection?
medRxiv
; 2022 Dec 04.
Article
in English
| MEDLINE | ID: mdl-36482974
8.
Autonomous sensory meridian response: Your patients already know, do you?
Cleve Clin J Med
; 87(12): 751-754, 2020 Nov 23.
Article
in English
| MEDLINE | ID: mdl-33229391
Results
1 -
8
de 8
1
Next >
>>